```json
{
"content": [
{
"type": "paragraph",
"content": "North America dominates the Aβ Monoclonal Antibody Drug market with a 45% share, driven by advanced healthcare infrastructure, high adoption of novel therapies, and robust investments from biopharma giants. Regulatory tailwinds from the FDA and a growing aging population further accelerate market growth."
},
{
"type": "paragraph",
"content": "Europe follows with a 30% share, fueled by a mature R&D ecosystem, favorable reimbursement policies, and collaborations between academia and industry. Germany and France lead in clinical adoption, while the UK’s post-Brexit life sciences strategy supports innovation."
},
{
"type": "paragraph",
"content": "Asia Pacific is the fastest-growing region at 15% CAGR, propelled by rising disposable incomes, expanding biotech ecosystems in China and India, and a surge in Alzheimer’s prevalence. Government initiatives like Japan’s Society 5.0 framework are critical enablers."
},
{
"type": "paragraph",
"content": Latin America and Middle East & Africa collectively represent 20% of the market, with growth stifled by fragmented healthcare access but showing potential through partnerships with global players and emerging market reforms."
}
],
"worldMapData": {
"regions": [
{ "name": "North America", "value": 45 },
{ "name": "Europe", "value": 30 },
{ "name": "Asia Pacific", "value": 15 },
{ "name": "Latin America", "value": 7 },
{ "name": "Middle East & Africa", "value": 3 }
]
}
}
```
